SLO2 and SLO4, novel potassium channel proteins from human brain
The invention provides isolated nucleic acid and amino acid sequences of Slo2 and Slo4, members of the Slo family of potassium channel proteins, also known as “maxi” or BK potassium channel proteins. Also provided herein are antibodies to Slo2 and Slo 4, methods of detecting Slo2 and Slo 4, methods of screening for potassium channel activators and inhibitors using biologically active Slo2 and Slo 4, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising Slo2 and Slo 4.
1. An isolated nucleic acid encoding a Slo2 polypeptide comprising an alpha subunit of a Slo potassium channel, the polypeptide:
(i) forming, with at least one additional alpha subunit, a potassium channel comprising the characteristic of voltage-gating; and
(ii) comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO:2.
2. The nucleic acid of claim 1 , wherein the potassium channel further comprises the characteristic of rapid activation.
3. The nucleic acid of claim 1 , wherein the nucleic acid comprises a nucleotide sequence of SEQ ID NO:1.
4. The nucleic acid of claim 1 , wherein the polypeptide encoded by the nucleic acid comprises an alpha subunit of a homomeric potassium channel.
5. The nucleic acid of claim 1 , wherein the polypeptide encoded by the nucleic acid comprises an alpha subunit of a heteromeric potassium channel.
6. An expression vector comprising the nucleic acid of claim 1 .
7. A host cell transfected with the vector of claim 6 .
8. The nucleic acid of claim 1 , wherein the polypeptide comprises SEQ ID NO:2.